WHO ICTRP trial

comparing the effect of Octreotide on non-variceal GI bleeding in children

IRCT20120415009475N6 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting

Key facts

Trial ID IRCT20120415009475N6
Public title comparing the effect of Octreotide on non-variceal GI bleeding in children
Scientific title Clinical trial for comparing standard treatment for non-variceal upper GI bleeding with and without Octreotide in pediatrics
Primary sponsor Shahid Beheshti University of Medical Sciences
Registry Iranian Registry of Clinical Trials (IRCT)
Recruitment status Not Recruiting
Study type interventional
Phase 2
Countries Iran (Islamic Republic of)
Conditions Gastrointestinal bleeding in children. Acute (erosive) gastritis with haemorrhage;K29.01
Interventions Intervention 1: Intervention group: patients will receive 1 to 2 micrograms of Octreotide per kilogram of body weight per hour until the cessation of bleeding. Every 50 micrograms will be infused in 50 milliliters of normal saline as a one…
Registration date Feb 14, 2019
Target size 50
Registry page irct.behdasht.gov.ir

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations